ANN ARBOR, Mich.--Eli Lilly has launched an 18-month software development program with Nonlinear Dynamics here that is designed to accelerate Lilly's drug discovery process. A team of six Nonlinear research scientists will work with chemoinformatics specialists at Lilly to develop datamining software to help reduce the time and expense required to identify high-potential compounds for further drug development and preclinical evaluation. Pilot testing of Nonlinear's preproduction software is scheduled to begin later this year, according to Lilly.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.